TY - JOUR
T1 - Live Attenuated Rev-Independent Nef-SIV Enhances Acquisition of Heterologous SIVsmE660 in Acutely Vaccinated Rhesus Macaques
AU - Byrareddy, Siddappa N.
AU - Ayash-Rashkovsky, Mila
AU - Kramer, Victor G.
AU - Lee, Sandra J.
AU - Correll, Mick
AU - Novembre, Francis J.
AU - Villinger, Francois
AU - Johnson, Welkin E.
AU - von Gegerfelt, Agneta
AU - Felber, Barbara K.
AU - Ruprecht, Ruth M.
N1 - Funding Information:
We thank Stephanie Ehnert and her staff for the coordination of the primate studies and collection of samples, Drs. Shenghua Duan and Yaoyu Wang of Center for Computational Biology at the Dana-Farber Cancer Institute for assistance in the microarray analysis, and Dr. Andre Rosowsky for critical reading of the manuscript. We acknowledge the NIH AIDS Research and Reference Reagent Program for the SIVsmE660 stock.
PY - 2013/9/30
Y1 - 2013/9/30
N2 - Background:Rhesus macaques (RMs) inoculated with live-attenuated Rev-Independent Nef- simian immunodeficiency virus (Rev-Ind Nef-SIV) as adults or neonates controlled viremia to undetectable levels and showed no signs of immunodeficiency over 6-8 years of follow-up. We tested the capacity of this live-attenuated virus to protect RMs against pathogenic, heterologous SIVsmE660 challenges.Methodology/Principal Findings:Three groups of four RM were inoculated with Rev-Ind Nef-SIV and compared. Group 1 was inoculated 8 years prior and again 15 months before low dose intrarectal challenges with SIVsmE660. Group 2 animals were inoculated with Rev-Ind Nef-SIV at 15 months and Group 3 at 2 weeks prior to the SIVsmE660 challenges, respectively. Group 4 served as unvaccinated controls. All RMs underwent repeated weekly low-dose intrarectal challenges with SIVsmE660. Surprisingly, all RMs with acute live-attenuated virus infection (Group 3) became superinfected with the challenge virus, in contrast to the two other vaccine groups (Groups 1 and 2) (P=0.006 for each) and controls (Group 4) (P=0.022). Gene expression analysis showed significant upregulation of innate immune response-related chemokines and their receptors, most notably CCR5 in Group 3 animals during acute infection with Rev-Ind Nef-SIV.Conclusions/Significance:We conclude that although Rev-Ind Nef-SIV remained apathogenic, acute replication of the vaccine strain was not protective but associated with increased acquisition of heterologous mucosal SIVsmE660 challenges.
AB - Background:Rhesus macaques (RMs) inoculated with live-attenuated Rev-Independent Nef- simian immunodeficiency virus (Rev-Ind Nef-SIV) as adults or neonates controlled viremia to undetectable levels and showed no signs of immunodeficiency over 6-8 years of follow-up. We tested the capacity of this live-attenuated virus to protect RMs against pathogenic, heterologous SIVsmE660 challenges.Methodology/Principal Findings:Three groups of four RM were inoculated with Rev-Ind Nef-SIV and compared. Group 1 was inoculated 8 years prior and again 15 months before low dose intrarectal challenges with SIVsmE660. Group 2 animals were inoculated with Rev-Ind Nef-SIV at 15 months and Group 3 at 2 weeks prior to the SIVsmE660 challenges, respectively. Group 4 served as unvaccinated controls. All RMs underwent repeated weekly low-dose intrarectal challenges with SIVsmE660. Surprisingly, all RMs with acute live-attenuated virus infection (Group 3) became superinfected with the challenge virus, in contrast to the two other vaccine groups (Groups 1 and 2) (P=0.006 for each) and controls (Group 4) (P=0.022). Gene expression analysis showed significant upregulation of innate immune response-related chemokines and their receptors, most notably CCR5 in Group 3 animals during acute infection with Rev-Ind Nef-SIV.Conclusions/Significance:We conclude that although Rev-Ind Nef-SIV remained apathogenic, acute replication of the vaccine strain was not protective but associated with increased acquisition of heterologous mucosal SIVsmE660 challenges.
UR - http://www.scopus.com/inward/record.url?scp=84884746235&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84884746235&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0075556
DO - 10.1371/journal.pone.0075556
M3 - Article
C2 - 24098702
AN - SCOPUS:84884746235
SN - 1932-6203
VL - 8
JO - PloS one
JF - PloS one
IS - 9
M1 - e75556
ER -